HER2-positive breast cancer cells resistant to trastuzumab and lapatinib lose reliance upon HER2 and are sensitive to the multitargeted kinase inhibitor sorafenib (Q39620638)
Jump to navigation
Jump to search
scientific article published on 9 December 2010
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | HER2-positive breast cancer cells resistant to trastuzumab and lapatinib lose reliance upon HER2 and are sensitive to the multitargeted kinase inhibitor sorafenib |
scientific article published on 9 December 2010 |
Statements
1 reference
HER2-positive breast cancer cells resistant to trastuzumab and lapatinib lose reliance upon HER2 and are sensitive to the multitargeted kinase inhibitor sorafenib (English)
1 reference
Annalisa Petrelli
1 reference
Giuliana Cavalloni
1 reference
Gianluca Zaccarello
1 reference
Giorgia Migliardi
1 reference
Andrea Milani
1 reference
Caterina Peraldo-Neia
1 reference
Loretta Gammaitoni
1 reference
Carla Pecchioni
1 reference
Aldo Moggio
1 reference
Filippo Montemurro
1 reference
9 December 2010
1 reference
1 reference
130
1 reference
1
1 reference
29-40
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference
1 reference